How to buy Globus Medical stock

Globus Medical, Inc is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Globus Medical employs 2,200 staff and has a trailing 12-month revenue of around 0.00.

Globus Medical share price

Use our graph to track the performance of GMED stocks over time.

Globus Medical shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$42.85 - $72.82
50-day moving average	$65.10
200-day moving average	$61.90
Wall St. target price	$71.47
PE ratio	71.7921
Dividend yield	N/A (0%)
Earnings per share (TTM)	$1.01

Buy Globus Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Globus Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Globus Medical, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Globus Medical under- or over-valued?

Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Globus Medical's P/E ratio

Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Globus Medical shares trade at around 72x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Globus Medical's PEG ratio

Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3465. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Globus Medical's EBITDA

Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $178.3 million.

The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.

Globus Medical financials

Revenue TTM	$789 million
Operating margin TTM	14.63%
Gross profit TTM	$571.6 million
Return on assets TTM	4.49%
Return on equity TTM	7.03%
Profit margin	12.96%
Book value	$15.11
Market capitalisation	$7.3 billion

TTM: trailing 12 months

Shorting Globus Medical shares

There are currently 1.5 million Globus Medical shares held short by investors – that's known as Globus Medical's "short interest". This figure is 26.8% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting Globus Medical shares can be evaluated.

Globus Medical's "short interest ratio" (SIR)

Globus Medical's "short interest ratio" (SIR) is the quantity of Globus Medical shares currently shorted divided by the average quantity of Globus Medical shares traded daily (recently around 479022.25705329). Globus Medical's SIR currently stands at 3.19. In other words for every 100,000 Globus Medical shares traded daily on the market, roughly 3190 shares are currently held short.

However Globus Medical's short interest can also be evaluated against the total number of Globus Medical shares, or, against the total number of tradable Globus Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Globus Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Globus Medical shares in existence, roughly 20 shares are currently held short) or 0.0199% of the tradable shares (for every 100,000 tradable Globus Medical shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Globus Medical.

Find out more about how you can short Globus Medical stock.

Globus Medical share dividends

We're not expecting Globus Medical to pay a dividend over the next 12 months.

Globus Medical share price volatility

Over the last 12 months, Globus Medical's shares have ranged in value from as little as $42.85 up to $72.82. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 1.0204. This would suggest that Globus Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Globus Medical overview

Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Frequently asked questions

• What percentage of Globus Medical is owned by insiders or institutions?

  Currently 1.106% of Globus Medical shares are held by insiders and 89.407% by institutions.

• How many people work for Globus Medical?

  Latest data suggests 2,200 work at Globus Medical.

• When does the fiscal year end for Globus Medical?

  Globus Medical's fiscal year ends in December.

• Where is Globus Medical based?

  Globus Medical's address is: 2560 General Armistead Avenue, Audubon, PA, United States, 19403

• What is Globus Medical's ISIN number?

  Globus Medical's international securities identification number is: US3795772082

• What is Globus Medical's CUSIP number?

  Globus Medical's Committee on Uniform Securities Identification Procedures number is: 379577208